Literature DB >> 807256

The effect of sulphide on cytochrome aa3. Isosteric and allosteric shifts of the reduced alpha-peak.

P Nicholls.   

Abstract

1. Sulphide, like cyanide, is a slow-binding inhibitor of cytochrome aa3 with a high affinity (KD smaller than 0.1 MUM). 2. Unlike cyanide binding, the binding of sulphide is apparently independent of the redox state of components of the oxidase other than cytochrome a3 and shows no anomalous kinetics during complex formation. 3. Sulphide binding to cytochrome a3-3+ is accompanied by a blue-shift in the alpha-peak of the reduced enzyme (a-2+ a3-3+ H2S), similar to but smaller than that induced by azide. 4. The reduced sulphide-inhibited system shows a much higher Soret peak at 445 nm than the corresponding cyanide and azide complexes, suggesting that partial electron transfer from sulphide to haem may occur in the complex. No evidence was obtained for the formation of any sulfhaem derivatives of cytochrome a3. 5. The influence of energization on the spectrum of mitochondrial cytochrome oxidase, and the effects of calcium on the alpha-peak of isolated cytochrome aa3 (Wikström, M.K.F. (1974) Ann. N.Y. Acad. Sci. 227, 146-158) are distinct from the action of the cytochrome a3 ligands. 6. A classification of peak shifts in the alpha-region in terms of isosteric and allosteric ligands is proposed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 807256     DOI: 10.1016/0005-2728(75)90186-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  34 in total

1.  Metabolic and cardiac signaling effects of inhaled hydrogen sulfide and low oxygen in male rats.

Authors:  Asaf Stein; Zhengkuan Mao; Joanna P Morrison; Michelle V Fanucchi; Edward M Postlethwait; Rakesh P Patel; David W Kraus; Jeannette E Doeller; Shannon M Bailey
Journal:  J Appl Physiol (1985)       Date:  2012-03-08

Review 2.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms.

Authors:  Csaba Szabo; Céline Ransy; Katalin Módis; Mireille Andriamihaja; Baptiste Murghes; Ciro Coletta; Gabor Olah; Kazunori Yanagi; Frédéric Bouillaud
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

3.  Cytochrome oxidase: an alternative model.

Authors:  C H Seiter; S G Angelos
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

4.  Binding of ligands and spectral shifts in cytochrome c oxidase.

Authors:  P Nicholls; V Hildebrandt
Journal:  Biochem J       Date:  1978-07-01       Impact factor: 3.857

5.  Development of hydrogen sulfide-based therapeutics for cardiovascular disease.

Authors:  Benjamin L Predmore; David J Lefer
Journal:  J Cardiovasc Transl Res       Date:  2010-07-14       Impact factor: 4.132

6.  Cumulative biochemical effects of repeated subclinical hydrogen sulfide intoxication in mouse brain.

Authors:  H Savolainen; R Tenhunen; E Elovaara; A Tossavainen
Journal:  Int Arch Occup Environ Health       Date:  1980       Impact factor: 3.015

Review 7.  A timeline of hydrogen sulfide (H2S) research: From environmental toxin to biological mediator.

Authors:  Csaba Szabo
Journal:  Biochem Pharmacol       Date:  2017-09-22       Impact factor: 5.858

8.  Unsuspected diversity of Niphargus amphipods in the chemoautotrophic cave ecosystem of Frasassi, central Italy.

Authors:  Jean-François Flot; Gert Wörheide; Sharmishtha Dattagupta
Journal:  BMC Evol Biol       Date:  2010-06-09       Impact factor: 3.260

Review 9.  Chemical Biology of H2S Signaling through Persulfidation.

Authors:  Milos R Filipovic; Jasmina Zivanovic; Beatriz Alvarez; Ruma Banerjee
Journal:  Chem Rev       Date:  2017-11-07       Impact factor: 60.622

10.  The loss of the hemoglobin H2S-binding function in annelids from sulfide-free habitats reveals molecular adaptation driven by Darwinian positive selection.

Authors:  Xavier Bailly; Riwanon Leroy; Susan Carney; Olivier Collin; Franck Zal; Andre Toulmond; Didier Jollivet
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.